Houston
US Sunbelt mayors push back against Trump’s virus optimism
US Sunbelt mayors warned Sunday that their cities are at risk of being overwhelmed by a surge of coronavirus cases as they pushed back against US President Donald Trump’s attempt to minimize the gravity of the spreading virus. COVID-19 has been raging for weeks across southern and western states. Florida has registered 10,000 new cases on some days. Arizona has seen record hospitalizations. And intensive care units in Houston, Texas are operating near maximum capacity. With President Trump continuing to play down the disease eschewing a mask, continuing to address large gatherings, saying a vaccine is only months away and asserting that “99 percent” of cases are not serious the exasperation of local officials has begun to boil over, with some floating the idea of new stay-at-home orders. “...
Regular Ish: James Harden And Lil Baby Spotted Whipping A Lamborghini In Houston
Source: photo: Derrick Salters/WENN.com While the world continues to spin out of control James Harden is screaming that his life is good. He was seen doing the most in his city and a lot of people are envious. As spotted on Clutch Points the all-star basketball player is living his best life with the help of one of Hip-Hop’s brightest stars. On June 25 Harden was spotted in Houston enjoying one of his many luxury vehicles in epic fashion. The shooting guard was pushing his all black Lamborghini Murcielago to the limit on an undetermined highway; luckily the someone captured footage of the joy ride. While the vibes looked lit things got even more interesting when it was made clear Lil Baby was joining him on the fun. When the clip opens we see Lil Baby also driving a white Lamborgini w...
Pfizer, BioNTech dose U.S first participants of trial coronavirus vaccine
Pfizer Inc. and BioNTech SE announced on Wednesday, May 6, 2020, that the first participants have been dosed in the U.S in the Phase 1/2 clinical trial for the BNT162 vaccine program to prevent COVID-19. The trial is part of a global development program, and the dosing of the first cohort in Germany was completed last week. The Phase 1/2 study is designed to determine the safety, immunogenicity and optimal dose level of four mRNA vaccine candidates evaluated in a single, continuous study. The dose level escalation portion (Stage 1) of the Phase 1/2 trial in the U.S will enrol up to 360 healthy subjects into two age cohorts (18-55 and 65-85 years of age). The first subjects immunized in Stage 1 of the study will be healthy adults 18-55 years of age. Older adults will only be immunized with ...
